ADC Therapeutics SA (ADCT) Financials

ADCT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 354.8 million 503.0 million
2023-09-30 466.9 million 521.1 million
2023-06-30 507.3 million 515.9 million
2023-03-31 467.7 million 430.0 million

ADCT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -33.4 million 1.6 million
2023-09-30 -34.7 million 2.5 million
2023-06-30 -38.0 million 1.1 million
2023-03-31 -15.8 million 8.3 million

ADCT Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 -85.7 million
2023-09-30 -47.8 million
2023-06-30 -47.1 million
2023-03-31 -59.4 million

ADCT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 278.6 million - 11.6 million
2023-09-30 310.4 million - 11.5 million
2023-06-30 347.5 million - 12.4 million
2023-03-31 310.5 million - 12.4 million

ADCT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 82.3 million
2023-09-30 82.3 million
2023-06-30 81.5 million
2023-03-31 80.8 million

ADCT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 327000 30.3 million 17.2 million 9.3 million
2023-09-30 661000 28.4 million 15.1 million 8.0 million
2023-06-30 1.2 million 31.9 million 12.6 million 8.3 million
2023-03-31 1.0 million 39.5 million 15.1 million 15.4 million

ADCT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 16.8 million 1.2 million
2023-09-30 14.5 million 366000
2023-06-30 19.3 million 1.3 million
2023-03-31 19.0 million 590000

ADCT

Price: $4.90

52 week price:
0.36
6.04

Earnings Per Share: -2.94 USD

P/E Ratio: -1.65

Exchange: NYQ

Sector: Healthcare

Industry: Biotechnology

Volume: 1.0 million

Market Capitalization: 412.6 million

Links: